Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

SkinJect

SkinJect
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
PE Growth LATEST DEAL TYPE
6 FINANCING ROUNDS
Description

Developer of micro-needle patch designed to treat non-melanoma skin cancers. The company's micro-needle patch is a medical device which comprises a dissolvable micro-needle array to deliver a drug directly into the top layer of skin to kill non-melanoma skin cancer by causing an immune system reaction to combat the disease, enabling patients to recover skin cancer.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 285 Kappa Drive
  • Suite 100
  • Pittsburgh, PA 15238
  • United States

+1 (412) 000-0000

SkinJect Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore SkinJect‘s full profile, request access.

Request full access to PitchBook

SkinJect Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore SkinJect‘s full profile, request access.

Request full access to PitchBook

SkinJect Executive Team (5)

Name Title Board
Seat
Contact
Info
James Nolan Chief Executive Officer & Board Member
Joseph Donnelly Chief Financial Officer & Board Member
Michael Fare Chief Operating Officer, Board Member & Chief Sales Officer
Louis Falo Jr. Co-Founder & Chief Medical Advisor
O. Burak Ozdoganlar Ph.D Co-Founder & Chief Technical Advisor

SkinJect Board Members (4)

Name Representing Role Since Contact
Info
0000000 00000000 SkinJect Board Member 000 0000
00000 00000 SkinJect Chief Executive Officer & Board Member 000 0000
000000 00000000 SkinJect Chief Financial Officer & Board Member 000 0000
0000000 000000 SkinJect Chairman 000 0000